Elicera Therapeutics AB (ELIC) — Free Cash Flow Generation Index
Latest as of December 2023:
1.00x
Elicera Therapeutics AB (ELIC) has a Free Cash Flow Generation Index of 1.00x as of December 2023. Free cash flow of Skr3.50 Million represents 1% of operating cash flow (Skr3.50 Million). Explore Elicera Therapeutics AB capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
1.00x
Free Cash Flow / Operating CF
Free Cash Flow
Skr3.50 Million
SEK
Operating Cash Flow
Skr3.50 Million
SEK
Capital Expenditures
Skr1.00K
SEK
Annual Free Cash Flow Generation for Elicera Therapeutics AB (None–None)
Year-by-year Free Cash Flow Generation Index for Elicera Therapeutics AB. Check Elicera Therapeutics AB (ELIC) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (SEK) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).